Interleukin-1β induces ceruloplasmin and ferroportin-1 gene expression via MAP kinases and C/EBPβ, AP-1, and NF-κB activation

Neuroscience Letters

Volumn 484, Issue 2, 2010, Pages 133-138

  Persichini, Tiziana ^a   Maio, Nunziata ^a   di Patti, Maria Carmela Bonaccorsi ^b   Rizzo, Gianluca ^a   Colasanti, Marco ^a   Musci, Giovanni ^a,c  

^a ROMA TRE UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

Astrocyte; Ceruloplasmin; Ferroportin; Interleukin 1 ; Iron

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CERULOPLASMIN; FERROPORTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IRON TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CERULOPLASMIN; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1BETA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EID: 77956880580     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.08.034     Document Type: Article

References (27)

1. Ahn J.D., Morishita R., Kaneda Y., Lee S.J., Kwon K.Y., Choi S.Y., Lee K.U., Park J.Y., Moon I.J., Park J.G., Yoshizumi M., Ouchi Y., Lee I.K. Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo. Circ. Res. 2002, 90:1325-1332.
2. Ara T., Declerck Y.A. Interleukin-6 in bone metastasis and cancer progression. Eur. J. Cancer 2010, 46:1223-1231.
3. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13681-13686.
4. Bingle C.D., Fleming R.E., Gitlin J.D. Interaction of CCAAT/enhancer-binding protein alpha and beta with the rat caeruloplasmin gene promoter. Biochem. J. 1993, 294(Pt 2):473-479.
5. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
6. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995, 364:229-233.
7. Das D., Tapryal N., Goswami S.K., Fox P.L., Mukhopadhyay C.K. Regulation of ceruloplasmin in human hepatic cells by redox active copper: identification of a novel AP-1 site in the ceruloplasmin gene. Biochem. J. 2007, 402:135-141.
8. De Domenico I., Ward D.M., di Patti M.C., Jeong S.Y., David S., Musci G., Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007, 26:2823-2831.
9. di Patti M.C., Persichini T., Mazzone V., Polticelli F., Colasanti M., Musci G. Interleukin-1beta up-regulates iron efflux in rat C6 glioma cells through modulation of ceruloplasmin and ferroportin-1 synthesis. Neurosci. Lett. 2004, 363:182-186.
10. Dringen R., Bishop G.M., Koeppe M., Dang T.N., Robinson S.R. The pivotal role of astrocytes in the metabolism of iron in the brain. Neurochem. Res. 2007, 32:1884-1890.
11. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7686-7689.
12. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273:18623-18632.
13. Fleming R.E., Gitlin J.D. Structural and functional analysis of the 5'-flanking region of the rat ceruloplasmin gene. J. Biol. Chem. 1992, 267:479-486.
14. Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 2003, 278:27144-27148.
15. Karin M., Delhase M. JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:9067-9069.
16. Kirkwood K.L., Rossa C. The potential of p38 MAPK inhibitors to modulate periodontal infections. Curr. Drug Metab. 2009, 10:55-67.
17. Kuhlow C.J., Krady J.K., Basu A., Levison S.W. Astrocytic ceruloplasmin expression, which is induced by IL-1beta and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor. Glia 2003, 44:76-84.
18. Lee C.M., Lo H.W., Shao R.P., Wang S.C., Xia W., Gershenson D.M., Hung M.C. Selective activation of ceruloplasmin promoter in ovarian tumors: potential use for gene therapy. Cancer Res. 2004, 64:1788-1793.
19. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
20. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
21. Obata T., Brown G.E., Yaffe M.B. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med. 2000, 28:N67-N77.
22. Patel B.N., David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 1997, 272:20185-20190.
23. Persichini T., Maio N., di Patti M.C., Rizzo G., Colasanti M., Musci G. Genistein up-regulates the iron efflux system in glial cells. Neurosci. Lett. 2010, 470:145-149.
24. Peyssonnaux C., Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 2001, 93:53-62.
25. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., Gerritsen M.E. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 1997, 272:21096-21103.
26. Sow F.B., Alvarez G.R., Gross R.P., Satoskar A.R., Schlesinger L.S., Zwilling B.S., Lafuse W.P. Role of STAT1, NF-kappaB, and C/EBPbeta in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-gamma. J. Leukoc. Biol. 2009, 86:1247-1258.
27. Stylianou E., Saklatvala J. Interleukin-1. Int. J. Biochem. Cell Biol. 1998, 30:1075-1079.